Alan L. Hillman

ALAN L. HILLMAN, director, Center for Health Policy at the Leonard Davis Institute of Health Economics and associate professor of medicine and health care management, School of Medicine and the Wharton School, University of Pennsylvania, Philadelphia An adviser to the White House Task Force on National Health Policy Reform, Alan Hillman started his career as a physician. He soon grew frustrated with a health care system that ignore

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ALAN L. HILLMAN, director, Center for Health Policy at the Leonard Davis Institute of Health Economics and associate professor of medicine and health care management, School of Medicine and the Wharton School, University of Pennsylvania, Philadelphia

An adviser to the White House Task Force on National Health Policy Reform, Alan Hillman started his career as a physician. He soon grew frustrated with a health care system that ignored the broader socioeconomic context of medical practice and seemed to encourage waste, such as "prescribing

MRI's for headaches when no test at all would be satisfactory." This led Hillman to pursue an M.B.A. degree and closely examine the appropriate allocation of health care resources. He now forecasts key trends in health care economics as director of the University of Pennsylvania's Center for Health Care Policy, a leading academic and policy research think tank.

Hillman's goal is to provide decision makers with information ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies